Skip to main content
. 2014 Oct 28;20(40):14537–14558. doi: 10.3748/wjg.v20.i40.14537

Table 5.

Clinical trials with everolimus in previously treated patients with advance gastric cancer and gastro-esophageal junction cancer

Trial Phase Setting Regimen Patients (n) OS (mo) PFS (mo)
NCT00985192[137], 2010 II Advanced Eve 53 10.1 2.7
NCT00879333[138], 2013 III Advanced Eve + BSC 656 5.4 1.7
BSC 4.3 1.4
NCT01248403[139], Ongoing III Advanced Eve + PTX 480 - -
PTX

Eve: Everolimus; PTX: Paclitaxel; OS: Overall survival; PFS: Progression free survival.